Page 68 - Pharma

US based Purdue Pharma renews IT contract with HCL

Agreement renews and expands partnership to drive continued business value from infrastructure and application operations

Take Supply Chain launches SaaS-based supply chain collaboration solution

The latest version of OneSCM delivers global tax support, integrated web help, and enhancements including data integration for customers running JD Edwards

Cipla acquires 60% in Sri Lankan firm for $14 mn

The acquired company will market Cipla's products in Sri Lanka

Arvind Remedies inks MoU with Adesh University

As per the agreement, the university will transfer the patent right to the company for manufacturing and marketing of formulation products from botanical source

Lupin launches generic ciprofloxacin suspension in the US

The company, which is the first applicant to file an ANDA for Cipro oral suspension, is entitled to 180 days of marketing exclusivity

US FDA completes inspection of Granules India's facility

The company's paracetamol facility has successfully passed a US FDA inspection without any 483 observations

Jubilant Life raises niacinamide price by 9%

The company is one of the leading players in vitamin B3 (niacin & niacinamide) globally

Nectar Lifesciences' Baddi facility receives European cGMP approval for cephalosporin

The company is also expected to receive US FDA approval very soon

Thermo Scientific's new molecular biology tools fasten lab analysis

New convenience features and rapid protocols leave more time for analysis and discovery

Strides Arcolab receives US FDA approval for methoxsalen

The company will manufacture the product at its US FDA approved oral dosage facility at Bangalore

Chinese pharma intermediates may become uncompetitive compared to India: Ashwin Shroff, Excel Industries Ltd

Interview with Ashwin Shroff, Chairman & Managing Director, Excel Industries Ltd

FDA alerts drive quality requirements upwards in pharma industry: Albert Stevens, IMCD Group

In this interview, Albert Stevens, VP Asia, IMCD Group, one of the leading global distributors of speciality chemicals, considers India to be one of the key growth drivers in Asia for the group

Eliminating microbial contamination with eco-friendly clean-in-place systems

Food and drug safety standards demand effective cleaning procedures to eliminate microbial contamination. Hence, integrated clean-in-place systems are finding increased acceptance in the pharma indust

Low-valued Re causing concern for analytical equipment makers

But manufacturers, providing high-end technologies, are still banking on India as research and quality take centre stage

Indian CMOs to seize branded generics market opportunities?

Increasing share of branded generics in the global pharmaceutical industry presents major opportunity for Indian CMOs provided they adhere to high quality standards

Value-addition must for Indian API makers to take on the Dragon challenge

To counter the challenge of rising API imports from China, Indian pharma industry should focus on value addition and high-potency products

Indian bulk drug industry: Maintain quality conscience to face competition

To gain long-term advantage, Indian pharmaceutical industry should compete on quality and not on cost

Invest in hygiene to reap long-term dividend

It is myth that cleaning is costly. On the contrary, it has high RoI as it improves productivity and increases customer retention

Optimising IT resources in pharma industry with right governance tools

In highly connected world, safeguarding sensitive information of a pharmaceutical company is of paramount importance. Hence, adopting right IT governance framework is imperative

EID Parry acquires Bayer's Chilean unit Alimtec

The acquisition will help EID Parry to ensure reliable sourcing of astaxanthin for its subsidiary, US Nutraceuticals LLC (Valensa)